AI assistant
Sending…
METLIFE INC — Director's Dealing 2019
Feb 28, 2019
29995_dirs_2019-02-28_330639b4-d7de-4c05-abb2-3bdc7c6875d0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: METLIFE INC (MET)
CIK: 0001099219
Period of Report: 2019-02-26
Reporting Person: TADROS RAMY (EVP & Chief Risk Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-02-26 | Employee Stock Option (Right to Buy) | $44.65 | A | 20162 | Acquired | 2029-02-25 | Common Stock (20162) | Direct |
| 2019-02-26 | Restricted Stock Units | $ | A | 6719 | Acquired | Common Stock (6719) | Direct |
Footnotes
F1: The options become exercisable in three installments on February 26, 2020, 2021 and 2022.
F2: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock.
F3: The Restricted Stock Units vest in three installments on March 2, 2020, March 1, 2021 and March 1, 2022.
More from METLIFE INC
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 6
Annual Report
2026
Apr 29
Regulatory Filings
2026
Apr 7
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 20
Regulatory Filings
2026
Mar 20
Regulatory Filings
2026
Mar 20
Regulatory Filings
2026
Mar 20
Director's Dealing
2026
Mar 19